Position in MRVI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,182,016
+$3,291,842 QoQ
Shares Held
1,471,477
-29.3% QoQ
Ownership
0.567%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#30
of 177 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. MRVI ranks #73 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in MRVI
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,182,016 | 1,471,477 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $5,890,174 | 2,081,334 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $6,500,903 | 2,000,278 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $3,768,381 | 1,313,025 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $776,284 | 322,110 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $870,766 | 394,012 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $15,142,807 | 2,778,497 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $128,181 | 15,425 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $28,674,969 | 4,004,884 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $41,873,897 | 4,829,746 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $17,340,030 | 2,647,333 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $7,575,370 | 757,537 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $670,287 | 53,925 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $24,558,675 | 1,752,939 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $39,219,359 | 2,740,696 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $53,026,728 | 2,077,036 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $15,294,693 | 538,356 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $17,677,747 | 501,212 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $16,542,454 | 394,808 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $73,031,825 | 1,488,016 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,086,517 | 73,964 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $8,453,273 | 237,185 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $10,181,589 | 362,980 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||